AstraZeneca Balance Sheet Health

Financial Health criteria checks 3/6

AstraZeneca has a total shareholder equity of $39.6B and total debt of $32.4B, which brings its debt-to-equity ratio to 81.8%. Its total assets and total liabilities are $104.3B and $64.7B respectively. AstraZeneca's EBIT is $12.3B making its interest coverage ratio 13.6. It has cash and short-term investments of $7.1B.

Key information

81.8%

Debt to equity ratio

US$32.40b

Debt

Interest coverage ratio13.6x
CashUS$7.08b
EquityUS$39.60b
Total liabilitiesUS$64.74b
Total assetsUS$104.34b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: AZNS's short term assets ($25.4B) do not cover its short term liabilities ($28.6B).

Long Term Liabilities: AZNS's short term assets ($25.4B) do not cover its long term liabilities ($36.2B).


Debt to Equity History and Analysis

Debt Level: AZNS's net debt to equity ratio (64%) is considered high.

Reducing Debt: AZNS's debt to equity ratio has reduced from 139.7% to 81.8% over the past 5 years.

Debt Coverage: AZNS's debt is well covered by operating cash flow (34.1%).

Interest Coverage: AZNS's interest payments on its debt are well covered by EBIT (13.6x coverage).


Balance Sheet


Discover healthy companies